A company purpose-built for personalized therapies From the beginning, Vineti’s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. The emerging ecosystem of cell therapies, gene therapies, and personalized cancer vaccines requires new enabling technologies to align and manage production processes and the patient journey. Our patent pending Personalized Therapy Management (PTM) platform provides the next-generation technology that advanced therapies need. In 2019, the World Economic Forum selected Vineti for its prestigious Technology Pioneer honor, as a company with the potential to “improve society for years to come.”